Simulations Plus Inc (NASDAQ: SLP) has reported E.P.S. of $0.10 for its first fiscal quarter (ending November 30) versus $0.06 for the same period a year ago — an increase of 67%. However, this performance […]
Recent significant negative changes in fundamentals have affected BlackBerry Ltd (NYSE: BB): significant quarterly sales deceleration occurred, the consensus estimate for February, 2023 decreased significantly, and the consensus estimate for February, 2024 decreased significantly. Important […]
On 1/2/24, XOMA Corp (NASDAQ: XOMA) stock enjoyed a major increase of 12.9%, closing at $20.89. Moreover, this advance was accompanied by exceptionally high trading volume at 270% of normal. The stock has risen 15.5% […]
MediWound Ltd (NASDAQ: MDWD) stock enjoyed a major increase of 10.6% on 1/2/24. The shares closed at $11.25. Moreover, this advance was accompanied by exceptionally high trading volume at 364% of normal. Relative to the […]
Extremely important negative changes in fundamentals have recently occurred for Stratasys Ltd (NASDAQ: SSYS): significant quarterly sales deceleration occurred, significant quarterly earnings deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and the consensus […]
Omega Flex Inc (NASDAQ: OFLX) stock suffered a major decline of -10.2% on 12/29/23. The shares closed at $70.51. Moreover, trading volume in this decline was exceptionally high at 247% of normal. The stock has […]
On 12/28/23, Flux Power Holdings Inc (NASDAQ: FLUX) stock enjoyed a major increase of 11.4%, closing at $3.82. Moreover, this advance was accompanied by exceptionally high trading volume at 577% of normal. Relative to the […]
AudioEye Inc (NASDAQ: AEYE) stock closed at $5.12 on 12/27/23 after a major increase of 14.0%. Moreover, this advance was accompanied by unusually high trading volume at 162% of normal. Relative to the market the […]
NovoCure Ltd (NASDAQ: NVCR) stock closed at $15.18 on 12/27/23 after a major increase of 12.2%. Moreover, unusually high trading volume at 152% of normal accompanied the advance. The stock has risen 13.3% during the […]
On 12/27/23, Zevra Therapeutics Inc (NASDAQ: ZVRA) stock enjoyed a major increase of 10.7%, closing at $5.48. Moreover, exceptionally high trading volume at 317% of normal accompanied the advance. The stock has risen 14.2% during […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research